期刊文献+

阿片类药物的滥用与丙型肝炎病毒感染 被引量:3

下载PDF
导出
出处 《中国药物依赖性杂志》 CAS CSCD 2008年第4期263-266,共4页 Chinese Journal of Drug Dependence
  • 相关文献

参考文献26

  • 1De Franeeseo R, Migliaeeio G. Challenges and successes in developing new therapies for hepatitis C[ J]. Nature, 2005, 436: 953 - 960
  • 2Garten RJ, Lai S, Zhang J, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China[J]. Inter J Epi, 2004, 33 : 182 - 188
  • 3Gale M, Jr, Foy EM. Evasion of intraeellular host defenee by hepatitis C virus[J]. Nature, 2005, 436:939 -945
  • 4Weber F, Kochs G, Hailer O. Inverse interference: how viruses fight the interferon system[ J ]. Viral Immunol, 2004, 17:498 -515
  • 5Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection[J]. J Virol, 2001,75:7059-7066
  • 6Taniguchi T, Takaoka A. A weak signal for strong responses: interferon -alpha/beta revisited [ J ]. Nat Rev Mol Cell Biol, 2001, 2 : 378 - 386
  • 7Katze MG, He Y, Gale M Jr. Viruses and interferon: a fight for supremacy[J]. Nat Rev Immunol, 2002, 2:675 -687
  • 8Zhang T, Lin RT, Li Y, et al. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines[J]. Hepatology, 2005, 42 : 819 - 827
  • 9Sato M, Suemori H, Hata N, et al. Distinct and essential roles of transcription factors IRF - 3 and IRF - 7 in response to viruses for IFN - alpha/beta gene induction [ J ]. Immunity, 2000, 13 : 539 - 548
  • 10Chisari FV. Unscrambling hepatitis C virus - host interactions[ J]. Nature, 2005, 436 : 930 - 932

同被引文献28

  • 1周宝桐,范蕴明,李德明,刘晓清.两种聚乙二醇干扰素联合利巴韦林治疗1b及6a亚型慢性丙型肝炎的疗效[J].中国医学科学院学报,2010,32(3):320-323. 被引量:14
  • 2苗翠英.论我国戒毒方法之优劣[J].中国人民公安大学学报(自然科学版),2005,11(1):42-45. 被引量:3
  • 3姬红瑞,张波,张锐敏,李吉祥,刘显玲,王华,宫雪梅.美沙酮维持病人的干预措施[J].中国药物滥用防治杂志,2006,12(2):107-108. 被引量:14
  • 4史捷,常武.常见毒品的分类及对人体的危害[J].科技咨询导报,2007(6):190-190. 被引量:12
  • 5李坤陶.毒品的种类及危害[J].生物学通报,2007,42(5):11-13. 被引量:11
  • 6Lee H Y, Kim Y K. Plasma brain-derived neurotrophic factor as a pe- ripheral marker for the action mechanism of antidepressants[ J]. Neu- ropsychobiology, 2008, 57 (4) : 194 - 199.
  • 7Chang S C, Ko W S, Wu S S, et al. Factors associated with quality of life in chronic hepatitis C patients who received interferon plus riba- virin therapy[J]. J Formos Med Assoe, 2008, 107(6) : 454 -462.
  • 8Sinakos E, Gigi E, Lalla T, et al. Health-related quality of life in Greek chronic hepatitis C patients during pegylated interferon and ribavirin treatment [ J ]. Hippokratia, 2010, 14 (2) : 122 - 125.
  • 9Sockalingam S, Abbey S E. Managing depression during hepatitis C treatment[J]. Can J Psychiatry-, 2009, 54(9) : 614 -625.
  • 10Raison C L, Broadwell S D, Borisov A S, et al. Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C [ J]. Brain Behav Immun, 2005, 19( 1 ) : 23 -27.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部